Dr
Courage
Chandipwisa
Dr
Courage
Chandipwisa
Dr
Pan African University Life and Earth Sciences (including Health and Agriculture)
LinkedIn
View profileBiography
MSc in Vaccine Production and Quality Control and a Doctor of Veterinary Medicine (DVM) with over three years of hands-on experience, I am deeply committed to advancing global health through the principles of One Health. My work focuses on the critical intersections between animal, human, and environmental health, addressing challenges such as zoonotic diseases, antimicrobial resistance (AMR), and the impacts of climate change.
I bring a unique blend of clinical, laboratory, and research expertise to my work, including disease prevention, treatment, and in-depth diagnostics for diverse veterinary species. My research interests center on vaccinology, zoonoses, and sustainable solutions to mitigate public health risks, ensuring safe and resilient food systems while promoting animal welfare.
Through my dedication to One Health and scientific innovation, I aim to contribute to the development of practical solutions that address pressing global health issues. Whether in the lab, field, or clinic, I strive to drive research and practices that safeguard both animal and human populations, ensuring healthier ecosystems worldwide. Research interests
Immunology has always intrigued me because of its direct impact on both human and animal health. During my veterinary training, I saw firsthand how zoonotic diseases could disrupt communities and realized that immunology held the potential to change that. Immunology bridges human and animal health, providing tools that can be used across species. This versatility and the power of immune responses to shape health outcomes across ecosystems were what drove me to pursue this field. It’s a branch of science that allows us to connect public health, research, and real-world solutions. Projects you're working on
Currently, I am conducting a study titled ‘A Comparative Evaluation of the Immunogenicity, Safety, and Potency of Cell Culture-Adapted Fowl Pox Vaccines.’ This project explores immune responses and the potential for enhanced vaccine performance, particularly for animal health, with insights that could be valuable for human vaccines as well.
Additionally, I’m involved in developing and testing adjuvant-enhanced vaccines targeting resistant respiratory pathogens, such as Streptococcus pneumoniae. These projects aim to tackle vaccine effectiveness against resistant pathogens, addressing a crucial need in global infectious disease management. Discipline
Bioinformatics Cellular biology Challenge study design Immunology – B-cells Immunology – T-cells Immunology – innate Host species
Cats Cattle Dogs Fish Poultry Wildlife Zoonoses Pathogen
Bacteria Bacteria›Salmonella Parasites Parasites›Taenia solium Parasites›Ticks Viruses Viruses›Foot-and-mouth disease virus Viruses›Herpesvirus Viruses›Influenza virus Viruses›Poxviruses Stage of vaccine development
Adjuvants Clinical trials Correlates of protection – immunomonitoring Field trials Vaccine delivery